PROF vs SNPS · rev $10.7M vs P/E 63, rev $7.05B
Profound Medical Corp (PROF) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
PROF currently screens at market cap $238.7M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the PROF and SNPS stock pages for the full models.
Not investment advice.